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Supplementary Fig. 1. Tropism of intravenously injected AAVs in the injured spinal 
cord acutely following T8 crush injury. (a, b) Representative images of longitudinal 
sections of the spinal cord infected with AAV2/9-CAG-H2B-GFP (a) or AAV2/7-CAG-
H2B-GFP (b) through tail vein injection before, or 3 h, 24 h, 3 d, or 7 d after a T8 crush. 
Similar distributions were observed in all of 3 analysed mice for each time point. Scale 
bar: 1 mm. (c, d)  Quantification of GFP expression in AAV2/9 and AAV2/7 groups. Mean 
±  SD is indicated by line and shadow with corresponding colour. a.u.: arbitrary unit. The 
fluorescence intensities were  normalized to that in AAV2/9 injected at 3h after injury (n = 
3 mice, 5 sections per mouse spanning the ventral to dorsal axis).  (e) Schematic of 
image locations shown in f-i. (f) Colocalization of AAV2/9-expressed H2B-GFP (green) 
with markers for neurons (NeuN, magenta) and oligodendrocytes/OPCs (Olig2, orange). 
AAV2/9-H2B-GFP signal, pseudo-coloured to indicate cells co-labeled with NeuN 
(neurons, magenta), Olig2 (oligodendrocytes/OPCs, orange), and for cells absent of 
NeuN or Olig2 (presumptive astrocytes, blue). Scale bar: 100 µm. (g) Co-labeling of 
infected cells (cytosolic GFP, green) with an astrocyte marker (GFAP, magenta). Scale 
bar: 300 µm. (h) Co-staining of transduced cells (H2B-GFP, green) with markers for 
endothelial cells (CD31, magenta) and pericytes (PDGFRβ, blue). Scale bar: 300 µm. (i) 
Co-labeling of infected cells (H2B-GFP, green) with a macrophage/microglia marker 
(CD68, red). Scale bar: 300 µm. Similar distributions were observed in all of 3 analysed 
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Supplementary Fig. 2. Characterization of T8 complete crush injury. (a, b) Images 
of the serial sections (every four 40 µm sections) stained with anti-5-HT antibodies from 
mice at 2 weeks (a) or 8 weeks (b) after injury. Scale bar: 500 µm. Enlarged images of 
boxed area show the regrowth of 5-HT fibres. (c, d) Scheme (c) and result (d) of 
quantification of the number of 5-HT axons per mouse in the spinal cord distal to the 
lesion site from serial sections spanning the ventral to dorsal axis. Data shown as mean 
± SD. 1mm: Two-tailed two sample t-test; 2mm: Wilcoxon rank sum test;  **p = 0.0022 (n 
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Supplementary Fig. 3. Kinematic results of hindlimb locomotion in injured mice 
with hM3Dq-assisted activation of thoracic neurons. (a) BMS scores of mice (4 
weeks after injury) with hM3Dq or control AAVs at indicated time points before and after 
CNO (1 mg/kg) injection. n = 7 (hM3Dq) and n = 5 (mCherry). Data shown as mean ± 
SD (also for the other panels of this figure). Repeated measures ANOVA followed by 
Bonferroni’s post hoc. ns: no statistical difference, p = 0.154 (before CNO); p = 0.154 (0 
min); ***p < 0.0001 (60 min, 180 min); **p = 0.0002 (120 min); 0.0050 (240 min) and 
0.002 (300 min). (b) Breakdown of behavioural performance categories. (c), a simplified 
stickview to show one step cycle of one hindlimb at free walking. The arrow depicts the 
direction of the movement and the measurement of different ankle joints and iliac crest 
height amplitude are also shown. (d-g) Quantification of average iliac crest height 
amplitude (d) and average angle oscillations of hip (e), knee (f) and ankle (g) of mice 
expressing excitatory hM3Dq before and after CNO (1 mg/kg) in comparison to intact 
mice. n = 6 for each group. One-Way ANOVA with Tukey’s post test for between-group 
(*) and two tailed paired t-tests for within-group (#) comparison. (d) *p = 0.011 
(mCherry), 0.04 (mCherry CNO), 0.010 (hM3Dq), ##p = 0.0088, ns: no statistical 
difference, p = 0.9746; (e) ***/###p < 0.001, ns p = 0.1717; (f) ***p < 0.001, ##p = 
0.0079; (g) ***/###p < 0.001,ns p = 0.0622. (h) Quantification of stepping frequencies of 
forelimbs and hindlimbs of WT mice with hm3Dq expression before and after CNO at 1 
mg/kg in comparison with intact mice. Data shown as mean ± SD. Two tailed sign test 
was used for within-group comparison (#) and Wilcoxon rank sum were used for 
between-group comparison (*). ##p = 0.0022; ***p < 0.001; *p = 0.0152. n = 6 for each 
group. (i, j) Quantification of average forelimbs toe height amplitude (i) and forelimbs 
step length (j) in mice expressing excitatory hM3Dq before and after CNO in comparison 
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Supplementary Fig. 4. hM3Dq-mediated activation of thoracic neurons elicits 
locomotion after T8 crush. (a, b) Left panels: EMG of selected muscles of the hind 
limbs in mice with hM3Dq expression before (a) and after (b) CNO (1mg/kg). Right 
panels: Probability density distributions of normalized EMG amplitudes in selected 
muscles during free walking. n=3 mice, 6-10 steps/mouse. (c) Representative images of 
in spinal cord sections from a wild type mouse with T8 crush and tail vein injection of 
AAV-Syn-hM3Dq-mCherry, n=8. Scale bars: 500 µm. (d, e) Quantification of number of 
responses after pinprick stimulation (d) or latency to withdraw after laser heat stimulation 
(e) Pinprick stimuli were applied 10 times per mouse. CNO administration concentration: 
1mg/kg. Laser heat was applied to plantar surface of either hindlimb and the average 
time to withdrawal of 3 trials was measured. n = 5 (intact) and n = 8 (SCI). Anova with 
repeated measures followed by Bonferroni’s post hoc for comparing intact vs SCI hMD3q 
(*) or different time points of SCI hMD3q (#). ##p = 0.0071; ***/###p < 0.001; #p = 
0.0103.  Data shown as mean ± SD. (f) Experimental outline and BMS scores of mice 
that received tail vein injection of inhibitory hM4Di at 3h after crush. Data shown are 



















































Supplementary Fig. 5. Verification of complete T8 crush injury in different groups. (a) 
Representative images showing serotonergic axons at T7, T10 or L2 of different groups of mice 
used in this study. Scale bars: 500 µm. (b) Quantification of 5-HT axon numbers from cross 
sections at T10 and L2 levels from WT, Vglut2-Cre, and Vgat-Cre mice at 8 weeks after injury. 
Data shown as mean ± SD. n = 7 (WT mice), n = 5 (vGlut2-Cre mice), n = 8 (Vgat-Cre mice). 
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Supplementary Fig. 6.  Activation of thoracic excitatory neurons improves 
standing but only minimal stepping in mice with T8 crush injury. (a) Quantification 
of stepping frequencies of Vglut2-Cre mice with expression of hM3Dq in thoracic 
excitatory neurons after administration of CNO (0.01 mg/kg), in comparison with intact 
mice. Data shown as mean ± SD for all panels in this figure. Two-tailed paired t-test was 
used for within-group comparison and Wilcoxon rank sum was used for between-group 
comparison (*). **p = 0.0002 (hM3Dq), 0.0004 (hM3Dq CNO). n=6 (intact) and n = 8 
(SCI). (b-e) Quantification of average amplitude of illiac crest heights (b) and average 
oscillation of hip (c) , knee (d) and ankle (e) joints. Two-tailed paired t-test was used for 
within-group (#) and 2 sample t-test was used for between group comparison (*). (b) ***/
###p < 0.0001, **p = 0.0078; (c) ***p < 0.0001, **p = 0.004; #p = 0.028; (d) ***/###p < 
0.0001, (e) ***p < 0.0001,**p = 0.006, ##p = 0.004. n = 6 (Intact) and n = 8 (hM3Dq). 
Data from intact mice are replotted from Figure S3c, d for comparison. (f) Quantification 
of spasms episodes in Vglut2-Cre mice with expression of excitatory hM3Dq in thoracic 
excitatory neurons after administration of indicated concentrations of CNO (n = 5). Two-
tailed paired t-test; **p = 0.0054 (1 mg/kg); 0.0033 (0.1 mg/kg); no statistical difference 
(ns) p = 0.1202.  (g) BMS scores (before and after CNO at 0.01mg/kg) of Vglut2-Cre 
mice with tail vein injection of AAV2/9-Syn-FLEX-hM3Dq at 3h or 24h after crush (3h 
data are replotted from Figure 3 for comparison). Two tailed paired t-test; ***p < 0.0001; 
*p = 0.0388. n= 5 (3h) and n = 4 (24h). (h) A representative image showing the 
distribution of transduced neurons in different spinal levels from Vglut2-Cre mice 
receiving tail vein injection of AAV2/9-CAG-FLEX-H2B-GFP at 3 hours after crush. 
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Supplementary Fig. 7. Inhibition of thoracic inhibitory neurons preferentially 
improves stepping ability in mice after T8 crush injury.  (a) Quantification of stepping 
frequencies of forelimbs and hindlimbs of Vgat-Cre mice with hM4Di expression before 
and after CNO at 5 mg/kg in comparison with intact mice. Data from intact mice are 
replotted from Supplementary Fig. S6a for comparison. (n=6 and 8 for intact and hM4Di 
respectively). Data shown as mean ± SD (also for other panels of this figure). Two-tailed 
sign test was used for within-group comparison (#) and Wilcoxon rank sum were used 
for between-group comparison (*); **p = 0.0033; ***p < 0.001; ##p = 0.0078. (b-e) 
Quantification of average amplitude of illiac crest heights (b) and average oscillation of 
hip (c) knee (d) and ankle (e) joints. Two-tailed paired t-test was used for within-group 
comparison (#) and 2 sample ttest was used for between-group comparison (*). (b) **p = 
0.004, #p = 0.0106, ns p = 0.5913; (c) ***/###p < 0.0001, **p = 0.0043; (d) ***p < 0.001, 
**p = 0.0013, ##p = 0.0078; (e) ***/###p < 0.001, n.s. p = 0.9352. n = 6 (Intact), n = 8 
(hM4Di). Data from intact mice from Figure S3c, d are replotted here for comparison. (f) 
A representative image showing distribution of GFP+ cells in different spinal levels from 
Vgat-Cre mice receiving tail vein injection of AAV2/9-CAG-FLEX-H2B-GFP after crush. 
















Supplementary Fig. 8. Histological data showing labelled neurons and axons by 
intersectional targeting of hM3Dq-mCherry in wild type mice. Representative images of 
longitudinal spinal sections showing the distribution of mCherry+ neurons and axons at low 
(left) and high exposure, in a wild-type mouse with intersectional targeted expression of 
hM3Dq-mCherry. Enlarged images of boxed area show the soma (low exposure) and axon 
projections (high exposure).  Scale bars: 1mm, n=3. 
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Supplementary Fig. 9. Manipulations of excitatory and/or inhibitory neurons in the 
lumbar spinal cord leads to different forms of spasms.  (a) Experimental Schematic. 
WT, Vglut2-Cre and Vgat-Cre mice (n = 4 per group) received a lumbar spinal cord 
injection of AAV2/1 versions of corresponding DREADDs 7-10 d before a T8 crush. (b) 
Representative images of longitudinal and cross spinal sections showing the distribution 
of mCherry+ neurons and axons. Similar patterns were observed in 3 different mice per 
group. Scale bars: 1mm (longitudinal section) and 500 µm (cross section). (c) Images 
showing representative depictions of muscle spasms observed in each group. (d) 
Representative EMG recordings of hip extensor, knee flexor and extensor, and ankle 
flexor and extensor before and after CNO in each group (WT mice: 1 mg/kg, Vglut2-Cre: 
0.01 mg/kg, Vgat-Cre: 5 mg/kg). (e)  Quantification of spasm frequencies in indicated 
groups of mice with CNO treatment. n = 4 for each group. (f) Quantification of EMG 
signals showing area under curve for indicated groups of mice after CNO, normalized 
with same mice before CNO application. Shown are means ± SD. One-Way ANOVA with 
Tukey’s post test; ns: no statistical difference, WT hM3Dq: *: p= 0.0229, **: p= 0.0058 
(ST), 0.0018(TA), ***: p < 0.0001, vGlut2-cre FLEX-hM3Dq: *: p=0.0439, ***: p < 0.0001; 
Vgat-Cre FLEX-hM4Di: *:p= 0.0439, ***: p < 0.000. n = 4 for each group. 






Supplementary table. Primers used for quantification of viral titres. 
